N17-N19
Acute kidney failure and chronic kidney disease
The ICD-10 block N17-N19 encompasses the broad spectrum of conditions related to renal failure, characterized by a significant impairment or cessation of kidney function. This range serves as a fundamental grouping within the ICD-10 system, guiding users to more specific, billable diagnoses within its sub-codes. It distinguishes between acute kidney failure (N17), which involves a sudden, often rapid, and potentially reversible decline in kidney function, and chronic kidney disease (N18), which represents a progressive, irreversible loss of renal function over an extended period. The code N19 is utilized for unspecified kidney failure when the acuity or specific type of renal failure cannot be determined or is not documented. As a non-billable category, N17-N19 facilitates the classification of renal dysfunction, emphasizing the critical distinction between acute and chronic presentations, which dictates different clinical management strategies and prognoses. Acute kidney failure is typically triggered by acute insults such as severe hypovolemia, sepsis, nephrotoxic medications, or obstructive uropathy, leading to a rapid accumulation of metabolic waste products and electrolyte imbalances. In contrast, chronic kidney disease is often a consequence of long-standing systemic diseases like diabetes mellitus, hypertension, and various primary renal diseases, progressing through stages of declining glomerular filtration rate (GFR) to end-stage renal disease. The codes within this block are invaluable for epidemiological tracking, healthcare resource allocation, and ensuring an accurate reflection of patient morbidity and disease burden. Precise documentation is paramount to select the most appropriate and specific billable code from the N17, N18, or N19 series, which detail specific etiologies, types, and stages of renal failure.
Clinical Symptoms
- Edema (swelling, particularly in legs, feet, or face)
- Fatigue and generalized weakness
- Shortness of breath
- Nausea, vomiting, or loss of appetite
- Changes in urine output (decreased or increased urination)
- Muscle cramps or twitching
- Persistent itching
- High blood pressure
- Confusion or difficulty concentrating (in severe cases)
- Metallic taste in mouth
- Dark urine or hematuria
Common Causes
- Acute Kidney Failure (N17):
- Severe dehydration or hypovolemia (prerenal causes)
- Sepsis or severe systemic infection
- Nephrotoxic medications (e.g., NSAIDs, certain antibiotics, contrast dyes)
- Obstruction of the urinary tract (e.g., kidney stones, enlarged prostate, tumors)
- Glomerulonephritis or vasculitis
- Rhabdomyolysis
- Hemolytic uremic syndrome (HUS)
- Chronic Kidney Disease (N18):
- Diabetes mellitus (diabetic nephropathy)
- Hypertension (high blood pressure)
- Glomerulonephritis (various types)
- Polycystic kidney disease and other inherited kidney diseases
- Chronic urinary tract obstructions (e.g., reflux nephropathy)
- Recurrent kidney infections (pyelonephritis)
- Autoimmune diseases (e.g., systemic lupus erythematosus)
- Analgesic nephropathy
- Long-term use of certain medications
Documentation & Coding Tips
Differentiate Acute Kidney Injury (AKI) from Chronic Kidney Disease (CKD) and specify the stage of CKD.
Example: Patient admitted with acute on chronic kidney disease. Baseline eGFR was 45 mL/min (CKD G3a) approximately 6 months ago. Current eGFR is 18 mL/min. Etiology of AKI is likely due to severe dehydration secondary to recent gastroenteritis (A09.0). Patient is now in AKI Stage 2 (based on KDIGO criteria, 2.5x increase in creatinine from baseline of 1.3 to current 3.2 mg/dL). The pre-existing CKD Stage 3a (N18.3) is documented as stable prior to this acute exacerbation. Patient also has Type 2 Diabetes Mellitus with diabetic nephropathy (E11.22) and essential hypertension (I10), which are long-standing contributors to CKD progression. Plan: Aggressive IVF resuscitation, strict I/O monitoring, daily renal function labs, temporarily hold ACEi/ARBs. Consult Nephrology for further management. This acute exacerbation increases the patient's severity of illness and risk for adverse outcomes. Baseline CKD is an active comorbidity.
Billing Focus: Clearly distinguishing AKI (N17.X) from CKD (N18.X), or documenting 'acute on chronic' (e.g., N17.9 with N18.3), is crucial for accurate diagnosis-related group (DRG) assignment and reimbursement. Specifying the stage of CKD (e.g., N18.3 for Stage 3a, N18.4 for Stage 4) impacts coding specificity. Linking the AKI to an underlying cause (e.g., dehydration, sepsis) is also critical for primary diagnosis sequencing.
Document the underlying cause(s) of the kidney disease and associated comorbidities with explicit causal links.
Example: Patient with known Chronic Kidney Disease, Stage 4 (N18.4), unequivocally secondary to long-standing Type 2 Diabetes Mellitus with diabetic nephropathy (E11.22) and poorly controlled essential (primary) hypertension (I10). Patient's current eGFR is 22 mL/min. Complications of CKD include severe anemia of chronic kidney disease (D63.1) requiring erythropoietin-stimulating agents, and uncontrolled secondary hyperparathyroidism (N25.81) for which the patient is on cinacalcet. Additionally, patient has a history of systolic heart failure (I50.22) which is closely managed due to cardiorenal implications. We are managing CKD progression by optimizing glycemic control (HbA1c 7.2%) with insulin glargine and managing BP with amlodipine and carvedilol. Patient is on a renal-friendly diet.
Billing Focus: Documenting the causal link (e.g., 'due to,' 'secondary to,' 'with,' 'related to') between conditions like diabetes/hypertension and CKD is essential for proper sequencing and justifies the complexity of care. For example, 'E11.22' (DM with diabetic nephropathy) is a more specific code than 'E11.9' (DM without complications) when nephropathy is present and directly linked to kidney disease. Complications like anemia (D63.1) and hyperparathyroidism (N25.81) further support the medical necessity of interventions and therapies.
Relevant CPT Codes
-
90935 - Hemodialysis procedure with single evaluation
Directly relevant for patients with End-Stage Renal Disease (N18.6) who require chronic hemodialysis for survival.
-
99214 - Established patient E/M, moderate complexity
Frequently used for routine follow-up of CKD patients (N18.X stages) to monitor progression, manage comorbidities, adjust medications, and provide patient education.
-
99291 - Critical care, first 30-74 minutes
Used for patients with severe Acute Kidney Injury (N17.X), especially in the setting of sepsis, cardiogenic shock, or multi-organ failure, requiring intensive monitoring and management in a critical care setting.
-
76770 - Ultrasound, kidney(s)
Used to assess kidney size, detect hydronephrosis (obstruction), identify cysts or masses, and evaluate renal artery stenosis, which can be causes or complications of kidney disease.
-
36819 - Arteriovenous fistula formation, upper extremity
Necessary for patients progressing to End-Stage Renal Disease (N18.6) who will require long-term hemodialysis for renal replacement therapy.
-
88305 - Level IV Surgical Pathology, Gross and Microscopic Examination
Performed to determine the specific etiology of rapidly progressive CKD, unexplained AKI, or certain glomerular diseases that lead to N17-N19 diagnoses, guiding targeted treatment.
Related Diagnoses
- N04.9 - Nephrotic syndrome, unspecified
- N13.8 - Other obstructive and reflux uropathy
- I12.9 - Hypertensive chronic kidney disease with stage 1 to 4 chronic kidney disease, or unspecified chronic kidney disease
- E11.22 - Type 2 diabetes mellitus with diabetic nephropathy
- I10 - Essential (primary) hypertension
- I50.9 - Heart failure, unspecified
- D63.1 - Anemia in chronic kidney disease
- E87.5 - Hyperkalemia
- Z99.2 - Dependence on dialysis
- N25.81 - Secondary hyperparathyroidism in end stage renal disease